1. TFOS Ambassadors

Brazil

Jose Gomes

Jose AP Gomes, MD, MsC, PhD, received his Medical Degree, Residency training, and Master's and Doctorate titles in São Paulo/SP, Brazil. In the USA, Dr. Gomes completed a Cornea and External Diseases Fellowship at the Wills Eye Hospital in Philadelphia and an Observer Fellowship in Ocular Immunology at Massachusetts Eye and Ear Infirmary in Boston. 
 
After his return to Brazil in 1995, Dr. Gomes became Associate Professor of Ophthalmology, Professor of the PhD Program, and Director of the Cornea Transplantation Residence Program at the Federal University of São Paulo (UNIFESP)/Paulista Medical School (EPM). At the same institution, he funded the Advanced Ocular Surface Center (CASO), the first Brazilian laboratory devoted to cellular therapy in ophthalmology. He also started a Fellowship Cornea Program at the Instituto Suel Abujamra (ISA) in São Paulo.
 
Dr. Gomes published 200 papers and received 35 awards and honors with emphasis on the areas of cornea, ocular surface, and dry eye disease, developing cut edge research in innovative clinical and surgical treatments, such as techniques for corneal, limbal, salivary gland and amniotic membrane transplantation, as well as cell therapy with different lineages of stem cells, keratoprosthesis, among others. He also published epidemiological studies about dry eye disease and cicatricial keratoconjunctivitis, and coordinated the Global Consensus of Keratoconus and Ectatic Diseases, which became a milestone in the keratoconus literature.
 
Dr. Gomes edited three books about ocular surface (2) and stem cells (1), and participated as author or co-author in 120 chapters in ophthalmology books. He is currently the associate editor of the journals Cornea, Ocular Surface, and Arquivos Brasileiros de Oftalmologia.
 
Dr. Gomes served as president of the PanAmerican Cornea Society (PanCornea), as a member of the board of the Cornea Society, and is now the president of the Brazilian Cornea Society (SBC). He also served on the board of the Tear Film Ocular Surface Society for 10 years, participating in the coordination of TFOS DEWS II and the TFOS Lifestyle workshop, and was a co-author of the recent TFOS DEWS III and Digest report.
 
Besides his academic activity, Dr. Gomes has a social concern, having founded and served as president of the Association of Dry Eye Patients (APOS), an NGO that aims to disseminate information and help needy patients with dry eye disease. In 2023, inspired by the TFOS Dry Eye Awareness month initiative, he idealized "Turquoise July" in Brazil, a campaign to disseminate information about this disease to health professionals and society through various initiatives.
 
< back

20 April

TFOS Guidelines

Ocular surface disease (OSD)—including dry eye disease, blepharitis, meibomian gland dysfunction, conjunctival inflammation, and cicatrizing ocular surface disorders—is one of the most common and underrecognized factors affecting the success of eye surgery (e.g., refractive, cataract, glaucoma, strabismus, retina, and oculoplastic). Conversely, optimizing the ocular surface is one of the most effective, modifiable strategies for enhancing surgical success across all ophthalmic subspecialties. And the central clinical principle appears to be universal: elective eye surgery...

17 April

EssilorLuxottica Partners with TFOS to Advance Ocular Surface Health Worldwide

TFOS is pleased to announce a new strategic partnership with EssilorLuxottica, a global leader in vision care and eyewear. This collaboration will support shared efforts to elevate awareness, education, and scientific progress in tear film and ocular surface health worldwide. By combining TFOS’s expertise in evidence-based consensus and professional education with EssilorLuxottica’s global reach and innovation capabilities, the partnership aims to help improve standards of care for patients affected by dry eye disease and related ocular surface conditions. Together, TFOS and EssilorLuxottica...

10 February

Latin American TFOS Ambassador Meeting

TFOS has organized a special meeting of the Latin American TFOS Ambassadors. This meeting, which will occur in Panama City this May, has two goals: first, to address the unmet needs for the management (e.g. diagnosis & treatment) of ocular surface diseases in their country/region, as well as what the Ambassadors perceive as short and long term scientific/clinical solutions; and second, to create a report for publication in a peer-reviewed journal. Participants will include TFOS Ambassadors from Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras,...

Corporate Advisory Board Members